Results overview: Found 39 records in 0.02 seconds.
Articles, 32 records found
Research literature, 6 records found
Course materials, 1 records found
Articles 32 records found  1 - 10nextend  jump to record:
1.
2 p, 536.6 KB Correction to : Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark / Ali, M. Sanni (Saint Paul Hospital Millennium Medical College. Department of Public Health) ; Ernst, Martin (University of Southern Denmark. Department of Public Health, Clinical Pharmacology and Pharmacy) ; Robinson, Danielle E. (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Caskey, Fergus (University of Bristol. Population Health Sciences) ; Arden, Nigel K. (MRC Lifecourse Epidemiology Unit) ; Ben-Shlomo, Yoav (University of Bristol. Population Health Sciences) ; Nybo, Mads (Odense University Hospital (Dinamarca)) ; Rubin, Katrine H. (University of Southern Denmark. Department of Health) ; Judge, Andrew (MRC Lifecourse Epidemiology Unit) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit) ; Javaid, M. K. (MRC Lifecourse Epidemiology Unit) ; Hermann, Anne P. (Odense University Hospital (Dinamarca)) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
2021 - 10.1007/s11657-021-01001-9
Archives of Osteoporosis, Vol. 16 (september 2021)  
2.
12 p, 944.6 KB Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease : an open cohort multivariable and propensity score analysis from Funen, Denmark / Ali, M. Sanni (London School of Hygiene and Tropical Medicine. Department of Non-communicable Disease Epidemiology) ; Ernst, Martin (University of Southern Denmark. Department of Public Health, Clinical Pharmacology and Pharmacy) ; Robinson, Danielle E. (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Caskey, Fergus (University of Bristol. Population Health Sciences) ; Arden, Nigel K. (MRC Lifecourse Epidemiology Unit) ; Ben-Shlomo, Yoav (University of Bristol. Population Health Sciences) ; Nybo, Mads (Odense University Hospital (Dinamarca)) ; Rubin, Katrine H. (University of Southern Denmark. Department of Health) ; Judge, Andrew (MRC Lifecourse Epidemiology Unit) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit) ; Javaid, M. K. (MRC Lifecourse Epidemiology Unit) ; Hermann, Anne P. (Odense University Hospital (Dinamarca)) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
Bisphosphonates are contraindicated in moderate-to-severe chronic kidney disease patients. However, they are used to prevent fragility fractures in patients with impaired kidney function, despite a lack of evidence on their effects on bone density in these patients. [...]
2020 - 10.1007/s11657-020-00746-z
Archives of Osteoporosis, Vol. 15 (june 2020)  
3.
11 p, 2.3 MB Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom / Recalde, Martina (Universitat Autònoma de Barcelona) ; Roel, Elena (Universitat Autònoma de Barcelona) ; Pistillo, Andrea (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Sena, Anthony G. (Erasmus University Medical Center. Department of Medical Informatics) ; Prats-Uribe, Albert (University of Oxford. Centre for Statistics in Medicine) ; Ahmed, Waheed-Ul-Rahman (University of Exeter. College of Medicine and Health) ; Alghoul, Heba (Islamic University of Gaza. Faculty of Medicine) ; Alshammari, Thamir M. (Riyadh Elm University. College of Pharmacy) ; Alser, Osaid (Harvard Medical School) ; Areia, Carlos (University of Oxford. Nuffield Department of Clinical Neurosciences) ; Burn, Edward (University of Oxford. Centre for Statistics in Medicine) ; Casajust, Paula (Real-World Evidence. Trial Form Support (Barcelona)) ; Dawoud, Dalia (Cairo University. Faculty of Pharmacy) ; DuVall, Scott L. (University of Utah School of Medicine. Department of Internal Medicine) ; Falconer, Thomas (Columbia University. Department of Biomedical Informatics) ; Fernández-Bertolín, Sergio (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Golozar, Asieh (Regeneron Pharmaceuticals. Pharmacoepidemiology) ; Gong, Mengchun (DHC Technologies) ; Lai, Lana Yin Hui (University of Manchester. Division of Cancer Sciences) ; Lane, Jennifer C. E. (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences) ; Lynch, Kristine E. (University of Utah School of Medicine. Department of Internal Medicine) ; Matheny, Michael E. (Vanderbilt University Medical Center. Department of Biomedical Informatics) ; Mehta, Paras P. (The University of Arizona. College of Medicine) ; Morales, Daniel R. (University of Dundee. Division of Population Health and Genomics) ; Natarjan, Karthik (New York-Presbyterian Hospital) ; Nyberg, Fredrik (University of Gothenburg. Institute of Medicine) ; Posada, Jose D. (Stanford University. Department of Medicine) ; Reich, Christian G. (Real World Solutions) ; Rijnbeek, Peter R. (Erasmus University Medical Center. Department of Medical Informatics) ; Schilling, Lisa M. (University of Colorado Anschutz Medical Campus. Department of Medicine) ; Shah, Karishma (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences) ; Shah, Nigam H. (Stanford University. Department of Medicine) ; Subbian, Vignesh (The University of Arizona. College of Engineering) ; Zhang, Lin (The University of Melbourne. Melbourne School of Population and Global Health) ; Zhu, Hong (Southern Medical University. Nanfang Hospital) ; Ryan, Patrick (Columbia University. Department of Biomedical Informatics) ; Prieto-Alhambra, Daniel (University of Oxford. Centre for Statistics in Medicine) ; Kostka, Kristin (Northeastern University. The OHDSI Center at the Roux Institute) ; Duarte-Salles, Talita (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. [...]
2021 - 10.1038/s41366-021-00893-4
International Journal of Obesity, Vol. 45 (july 2021) , p. 2347-2357  
4.
12 p, 9.5 MB Use of repurposed and adjuvant drugs in hospital patients with covid-19 : multinational network cohort study / Prats-Uribe, Albert (Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Sena, Anthony G (Department of Medical Informatics, Erasmus University Medical Center, Rotterdam) ; Lai, Lana Yin Hui (Division of Cancer Sciences, School of Medical Sciences, University of Manchester) ; Ahmed, Waheed-Ul-Rahman (College of Medicine and Health, University of Exeter) ; Alghoul, Heba (Faculty of Medicine, Islamic University of Gaza) ; Alser, Osaid (Harvard Medical School) ; Alshammari, Thamir M (College of Pharmacy, Riyadh Elm University) ; Areia, Carlos (Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford) ; Carter, William (University of Colorado Anschutz Medical Campus, Aurora) ; Casajust, Paula (Real-World Evidence, Trial Form Support, Barcelona) ; Dawoud, Dalia (National Institute for Health and Care Excellence, London) ; Golozar, Asieh (Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore) ; Jonnagaddala, Jitendra (School of Population Health, UNSW Sydney) ; Mehta, Paras P (College of Medicine, University of Arizona) ; Gong, Mengchun (DHC Technologies, Beijing) ; Morales, Daniel R (Department of Public Health, University of Southern Denmark) ; Nyberg, Fredrik (School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg) ; Posada, Jose D (Department of Medicine, Stanford University School of Medicine) ; Recalde, Martina (Universitat Autònoma de Barcelona) ; Roel, Elena (Universitat Autònoma de Barcelona) ; Shah, Karishma (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Shah, Nigam H (Department of Medicine, Stanford University School of Medicine, Stanford) ; Schilling, Lisa M (University of Colorado Anschutz Medical Campus, Aurora) ; Subbian, Vignesh (College of Engineering, University of Arizona Tucson) ; Vizcaya, David (Bayer Pharmaceuticals, Sant Joan Despí) ; Zhang, Lin (School of Population and Global Health, University of Melbourne, Melbourne) ; Zhang, Ying (DHC Technologies, Beijing) ; Zhu, Hong (Nanfang University, Southern Medical University, Guangzhou) ; Liu, Li (Nanfang University, Southern Medical University, Guangzhou) ; Cho, Jaehyeong (Department of Biomedical Informatics, Ajou University School of Medicine, Suwon) ; Lynch, Kristine E (VA Informatics and Computing Infrastructure, VA Salt Lake City Healthcare System; Department of Internal Medicine, University of Utah School of Medicine) ; Matheny, Michael E (Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville) ; You, Seng Chan (Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Seoul) ; Rijnbeek, Peter R (Department of Medical Informatics, Erasmus University Medical Center, Rotterdam) ; Hripcsak, George (Department of Biomedical Informatics, Columbia University, New York) ; Lane, Jennifer CE (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford) ; Burn, Edward (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Reich, Christian (IQVIA, Cambridge) ; Suchard, Marc A (Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles) ; Duarte-Salles, Talita (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Kostka, Kristin (OHDSI Center at The Roux Institute, Northeastern University, Portland) ; Ryan, Patrick B (Columbia University Irving Medical Center, New York) ; Prieto-Alhambra, Daniel (Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford)
To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-19 across three continents. Multinational network cohort study. Hospital electronic health records from the United States, Spain, and China, and nationwide claims data from South Korea. [...]
2021 - 10.1136/bmj.n1038
The BMJ, Vol. 373 (may 2021)  
5.
16 p, 1.3 MB Population trends in the incidence and initial management of osteoarthritis : age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013 / Yu, Dahai (Research Institute for Primary Care & Health Sciences, Keele University, Keele, UK) ; Jordan, Kelvin P (Research Institute for Primary Care & Health Sciences, Keele University, Keele, UK) ; Bedson, John (Research Institute for Primary Care & Health Sciences, Keele University, Keele, UK) ; Englund, Martin (Clinical Epidemiology Research & Training Unit, Boston University School of Medicine, Boston, MA, USA) ; Blyth, Fiona (Concord Clinical School, Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia) ; Turkiewicz, Aleksandra (Clinical Epidemiology Unit, Orthopaedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Peat, George (Research Institute for Primary Care & Health Sciences, Keele University, Keele, UK) ; Universitat Autònoma de Barcelona
To determine recent trends in the rate and management of new cases of OA presenting to primary healthcare using UK nationally representative data. Using the Clinical Practice Research Datalink we identified new cases of diagnosed OA and clinical OA (including OA-relevant peripheral joint pain in those aged over 45 years) using established code lists. [...]
2017 - 10.1093/rheumatology/kex270
Rheumatology, Vol. 56 (august 2017) , p. 1902-1917  
6.
8 p, 535.7 KB The impact of rheumatoid arthritis on the risk of adverse events following joint replacement : a real-world cohort study / Burn, Edward (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Edwards, Christopher J (NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton, Southampton, UK) ; Murray, David W (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Silman, Alan (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK) ; Arden, Nigel K (MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Pinedo-Villanueva, Rafael (MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK) ; Universitat Autònoma de Barcelona
To assess whether rheumatoid arthritis (RA) is associated with a greater risk of adverse events following total knee replacement (TKR) and total hip replacement (THR) than osteoarthritis (OA). Individuals with a diagnosis of RA or OA were identified using primary care records. [...]
2018 - 10.2147/CLEP.S160347
Clinical Epidemiology, Vol. 10 (june 2018) , p. 697-704  
7.
28 p, 649.1 KB COVID-19 in patients with autoimmune diseases : characteristics and outcomes in a multinational network of cohorts across three countries / Tan, Eng Hooi (University of Oxford. Centre for Statistics in Medicine) ; Sena, Anthony G (Erasmus University Medical Center) ; Prats-Uribe, Albert (University of Oxford. Centre for Statistics in Medicine) ; You, Seng Chan (Suwon) ; Ahmed, Waheed-Ul-Rahman (University of Exeter) ; Kostka, Kristin (Real World Solutions) ; Reich, Christian (Real World Solutions) ; Duvall, Scott L (Salt Lake City) ; Lynch, Kristine E (Salt Lake City) ; Matheny, Michael E (Vanderbilt University Medical Center) ; Duarte-Salles, Talita (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Bertolin, Sergio Fernandez (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Hripcsak, George (New York-Presbyterian Hospital) ; Natarajan, Karthik (New York-Presbyterian Hospital) ; Falconer, Thomas (Columbia University. Department of Biomedical Informatics) ; Spotnitz, Matthew (Columbia University) ; Ostropolets, Anna (Columbia University) ; Blacketer, Clair (Erasmus University Medical Center) ; Alshammari, Thamir M (King Saud Univeristy. Medication Safety Research Chair) ; Alghoul, Heba (Islamic University of Gaza) ; Alser, Osaid (Harvard Medical School) ; Lane, Jennifer C E (University of Oxford. Centre for Statistics in Medicine) ; Dawoud, Dalia M (Cairo University) ; Shah, Karishma (University of Oxford. Botnar Research Centre) ; Yang, Yue (DHC Technologies Co) ; Zhang, Lin (The University of Melbourne) ; Areia, Carlos (University of Oxford) ; Golozar, Asieh (Departament of Epidemiology) ; Recalde, Martina (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Casajust, Paula (Real-World Evidence) ; Jonnagaddala, Jitendra (UNSW Sydney) ; Subbian, Vignesh (The University of Arizona Tucson) ; Vizcaya, David (Bayer Pharmaceuticals) ; Lai, Lana Y H (University of Manchester) ; Nyberg, Fredrik (University of Gothenburg. Institute of Medicine) ; Morales, Daniel R (University of Dundee) ; Posada, Jose D (Stanford University. Stanford Center for Biomedical Informatics Research) ; Shah, Nigam H (Stanford University. Stanford Center for Biomedical Informatics Research) ; Gong, Mengchun (Southern Medical University. Health Management Institute) ; Vivekanantham, Arani (Botnar Research Centre. University of Oxford. Rheumatology) ; Abend, Aaron (Autoimmune Registry Inc) ; Minty, Evan P (University of Calgary. O'Brien School for Public Health) ; Suchard, Marc (University of California) ; Rijnbeek, Peter (Erasmus University Medical Center) ; Ryan, Patrick B (Columbia University) ; Prieto-Alhambra, Daniel (University of Oxford. Centre for Statistics in Medicine) ; Universitat Autònoma de Barcelona
Patients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking. We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza. [...]
2021 - 10.1093/rheumatology/keab250
Rheumatology, march 2021  
8.
10 p, 568.8 KB Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study / Engelkes, Marjolein (ErasmusMC) ; Baan, Esme J. (ErasmusMC) ; de Ridder, Maria A. J. (ErasmusMC) ; Svensson, Elisabeth (Aarhus University) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Lapi, Francesco (SIMG) ; Giaquinto, Carlo (University of Padova) ; Picelli, Gino ; Boudiaf, Nada (GlaxoSmithKline) ; Albers, Frank (Avillion US Inc) ; Evitt, Lee A. (GlaxoSmithKline) ; Cockle, Sarah (GlaxoSmithKline) ; Bradford, Eric (GlaxoSmithKline) ; Van Dyke, Melissa K. (GlaxoSmithKline) ; Suruki, Robert (UCB Biosciences) ; Rijnbeek, Peter (ErasmusMC) ; Sturkenboom, Miriam C. J. M. (Utrecht University Medical Center) ; Janssens, Hettie M. (University Medical Center Rotterdam) ; Verhamme, Katia M. C. (OLV Hospital) ; Universitat Autònoma de Barcelona
There are sparse real-world data on severe asthma exacerbations (SAE) in children. This multinational cohort study assessed the incidence of and risk factors for SAE and the incidence of asthma-related rehospitalization in children with asthma. [...]
2020 - 10.1111/pai.13237
Pediatric Allergy and Immunology, Vol. 31 (march 2020) , p. 496-505  
9.
10 p, 780.0 KB Secular trends in the initiation of therapy in secondary fracture prevention in Europe : a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom / Skjødt, M. K. (Odense University Hospital (Dinamarca)) ; Khalid, S. (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Ernst, M. (University of Southern Denmark. Department of Public Health, Clinical Pharmacology and Pharmacy) ; Rubin, K. H. (Odense University Hospital (Dinamarca)) ; Martínez-Laguna, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Delmestri, Antonella (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Javaid, M. K. (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, England) ; Libanati, C. (UCB Pharma) ; Toth, E. (UCB Pharma) ; Abrahamsen, B. (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Prieto-Alhambra, Daniel (Oxford University Hospitals. Nuffield Orthopaedic Centre)
This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88-90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. [...]
2020 - 10.1007/s00198-020-05358-4
Osteoporosis International, Vol. 31 (march 2020) , p. 1535-1544  
10.
15 p, 1.4 MB Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data : a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database / Khalid, Sara (Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom) ; Calderon-Larrañaga, Sara (Family and Community Medicine Teaching Unit of Granada. Cartuja University Health Centre. Andalusian Health Service (SAS), Granada, Spain) ; Hawley, Samuel (Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom) ; Ali, M Sanni (London School of Hygiene and Tropical Medicine, London, United Kingdom) ; Judge, Andrew (Bristol NIHR Biomedical Research Centre (Bristol, Regne Unit)) ; Arden, Nigel (University of Oxford. Arthritis Research UK Centre for Sport, Exercise, and Osteoarthritis) ; van Staa, Tjeerd (Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands) ; Cooper, Cyrus (NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom) ; Javaid, Muhammad Kassim (Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
This paper aims to compare the clinical effectiveness of oral anti-osteoporosis drugs based on the observed risk of fracture while on treatment in primary care actual practice. We investigated two primary care records databases covering UK National Health Service (Clinical Practice Research Datalink, CPRD) and Catalan healthcare (Information System for Research in Primary Care, SIDIAP) patients during 1995-2014 and 2006-2014, respectivey. [...]
2018 - 10.2147/CLEP.S164112
Clinical Epidemiology, Vol. 10 (october 2018) , p. 1417-1431  

Articles : 32 records found   1 - 10nextend  jump to record:
Research literature 6 records found  
1.
97 p, 4.3 MB Situació i avaluació de l'atenció de la fractura de maluc en la gent gran a Catalunya : estudi poblacional entre els anys 2012 i 2016 / Cancio Trujillo, José Manuel ; Diez Pérez, Adolfo, dir. ; Prieto-Alhambra, Daniel, dir. ; Santaeugènia Gonzàlez, Sebastià, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
La fractura de maluc (FM) és un problema primordial de salut en la gent gran. Aquest procés, a més de tenir associada una elevada mortalitat, pot ocasionar deteriorament important de la qualitat de vida i ser font de discapacitats i d'una elevada utilització de recursos sanitaris. [...]
Hip fracture (HF) is a primary health problem in the elderly. This process, in addition to having a high mortality associated, can lead to a significant deterioration in the quality of life, can be source of disabilities and can cause a high use of health resources. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2020.  
2.
82 p, 1.1 MB Efecto de la diabetes mellitus tipo 2 sobre la incidencia de fractura osteoporótica / Martínez Laguna, Daniel ; Prieto Alhambra, Daniel, dir. ; Nogués Solán, Xavier, dir. ; Díez Pérez, Adolfo, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Objetivos: La diabetes mellitus tipo 2 (DM2) y la osteoporosis son dos procesos prevalentes en las consultas de atención primaria y estrechamente relacionados. Paradójicamente, a pesar de que los pacientes DM2 presentan una mayor masa ósea, presentan un mayor riesgo de fractura. [...]
Aims: Type 2 diabetes mellitus (T2DM) and osteoporosis are two highly prevalent long-term comorbidities. Paradoxically, although T2DM patients have a higher bone mass, they present an increased risk of fracture. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
3.
291 p, 2.5 MB Tratamiento hospitalario de la fractura de fémur en españa: variabilidad y tendencias / Carbonell Abella, Cristina ; Prieto Alhambra, Daniel, dir. ; Nogués Solán, Xavier, dir. ; Díez Pérez, Adolfo, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Introducció. La fractura de maluc és un procés molt prevalent amb important repercussió clínica, social i econòmica. Conèixer com es desenvolupa la seva epidemiologia i tractament pot permetre'ns establir estratègies d'atenció més efectives en termes de salut i econòmics. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2016  
4.
87 p, 10.5 MB Característiques del compliment dels tractaments per a l'osteoporosi i característiques dels pacients amb resposta inadequada al tractament a Catalunya / Pagès Castellà, Aina ; Prieto Alhambra, Daniel, dir. ; Díez Pérez, Adolfo, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
L'osteoporosi és un trastorn esquelètic caracteritzat per una disminució en la resistència òssia que predisposa a la persona que el pateix a un risc augmentat de fractura. Els fàrmacs de primera elecció per al tractament de l'osteoporosi són els bifosfonats. [...]
Osteoporosis is a skeletal disorder characterized by a decrease in bone strength that predisposes the person who suffers it an increased risk of fracture. Bisphosphonates (BP) are the first choice drugs' for the osteoporosis treatment. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2015  
5.
16 p, 343.8 KB Riesgo de fractura asociado a los estadios previos al diagnóstico de la diabetes tipo 2 : estudio de caso-control anidado (cohorte DIAFOS) / Martínez Laguna, Daniel ; Prieto-Alhambra, Daniel ; Nogués Solán, Xavier ; Universitat Autònoma de Barcelona. Departament de Medicina ; Universitat Autònoma de Barcelona. Facultat de Medicina
El objetivo es comparar la prevalencia de fractura en casos incidentes de diabetes y en controles apareados.
L'objectiu és comparar la prevalença de fractura en casos incidents de diabetis i controls aparellats.

2013  
6.
32 p, 2.1 MB Epidemiologia de la fractura a l'atenció primària de catalunya / Pagès Castellà, Aina ; Díez Pérez, Adolfo ; Prieto Alhambra, Daniel ; Universitat Autònoma de Barcelona. Departament de Medicina ; Universitat Autònoma de Barcelona. Facultat de Medicina
Utilitzant una base de dades amb informació clínica extreta de l'historial d'Atenció Primària (AP) a Catalunya, hem portat a terme un estudi de cohorts retrospectiu l'any 2009, incloent individus  50 anys. [...]
2012  

Course materials 1 records found  
1.
10 p, 373.5 KB Recerca en Medicina Interna [42153] / Díez Pérez, Adolfo ; Nogués Solans, Xavier ; Prieto - Alhambra, Daniel ; Castells Oliveras, Xavier ; Martínez Rodríguez, José E. ; Webb, Susan ; Selva O'Callaghan, Albert ; Domingo Querol, Pere ; Farre, Magi ; Horcajada Gallego, Juan Pablo ; Gea Giralt, Joaquim ; Güerri Fernández, Roberto ; Sabrià Leal, Miquel ; Andreu García, Montserrat ; Pascual Santos, Julio ; Sancho Insenser, Joan ; Universitat Autònoma de Barcelona. Facultat de Medicina
El mòdul d'Investigació en Medicina Interna te l'objectiu fonamental d'iniciar als alumnes en el coneixements, habilitats i competències inherents a la investigació, fonamentalment clínica i traslacional, però també en els coneixements necessaris per a una interacció sinèrgica i eficient amb la investigació bàsica. [...]
2014-15  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.